Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Ironwood Pharmaceuticals (IRWD) Accumulated Depreciation & Amortization (2016 - 2025)

Ironwood Pharmaceuticals (IRWD) has disclosed Accumulated Depreciation & Amortization for 16 consecutive years, with $1.1 million as the latest value for Q4 2025.

  • Quarterly Accumulated Depreciation & Amortization fell 8.33% to $1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Dec 2025, down 8.33% year-over-year, with the annual reading at $1.1 million for FY2025, 8.33% down from the prior year.
  • Accumulated Depreciation & Amortization hit $1.1 million in Q4 2025 for Ironwood Pharmaceuticals, down from $1.2 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $1.5 million in Q4 2021 to a low of $1.1 million in Q4 2025.
  • Historically, Accumulated Depreciation & Amortization has averaged $1.3 million across 5 years, with a median of $1.2 million in 2023.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: plummeted 34.78% in 2021 and later changed 0.0% in 2024.
  • Year by year, Accumulated Depreciation & Amortization stood at $1.5 million in 2021, then fell by 6.67% to $1.4 million in 2022, then decreased by 14.29% to $1.2 million in 2023, then changed by 0.0% to $1.2 million in 2024, then fell by 8.33% to $1.1 million in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for IRWD at $1.1 million in Q4 2025, $1.2 million in Q4 2024, and $1.2 million in Q4 2023.